Inhalation of growth factors and apo-transferrin to protect and repair the hypoxic-ischemic brain

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Mariano Guardia ClausiJuana María Pasquini

Abstract

Hypoxic-ischemic brain damage is a major contributor to chronic neurological dysfunction and acute mortality in infants as well as in adults. In this review, we summarize recent publications demonstrating that the intranasal administration (INA) of apo-transferrin (aTf) and different growth factors provides neuroprotection to the mouse and rat brain after a hypoxic-ischemic event. The intranasal delivery of growth factors such as insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) has been found to improve neurological function and reduce infarct size in adult rats after a hypoxic-ischemic event. On the other hand, INA of aTf and epidermal growth factor (EGF) were effective in reducing white matter damage and inflammation and in promoting the proliferation and survival of oligodendroglial progenitor cells (OPCs) in a model of hypoxic-ischemic encephalopathy. Therefore, data summarized in this review suggest that INA of growth factors and aTf can be used in combination in clinical treatment in order to protect and repair the hypoxic-ischemic brain.

References

Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J M HillC B Pert
Jul 29, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·L Illum
Sep 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Simona CapsoniAntonino Cattaneo
Feb 26, 2003·Annals of Neurology·Kunlin JinDavid A Greenberg
May 16, 2003·Journal of Neuroscience Research·Maria-Carla SalehFlorian Guillou
Feb 26, 2004·The Journal of Pharmacy and Pharmacology·Lisbeth Illum
Oct 29, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cheolwha JungThomas B Shea
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Roberta De RosaAntonino Cattaneo
Jul 10, 2007·Nature Neuroscience·Adan AguirreVittorio Gallo
May 7, 2008·Journal of Neuroscience Research·M E BadaraccoJ M Pasquini
Jun 6, 2008·Alzheimer Disease and Associated Disorders·Viral V JoganiAmbikanandan R Misra
Jan 20, 2009·Recent Patents on Drug Delivery & Formulation·Shadab A PathanFarhan J Ahmad
Mar 28, 2009·European Journal of Cell Biology·Lusine DanielyanWilliam H Frey
Jun 11, 2009·The Journal of Pharmacology and Experimental Therapeutics·Leah R HansonS Scott Panter
Jun 30, 2009·Neuroscience Letters·Ji-Ping YangXin-Feng Liu
Oct 8, 2009·Journal of Drug Targeting·Sandra R Alcalá-BarrazaLinda K McLoon
Nov 30, 2010·ASN Neuro·Mariano Guardia ClausiJuana M Pasquini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.